tiprankstipranks
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
Want to see GALT full AI Analyst Report?

Galectin Therapeutics (GALT) Revenue

670 Followers

Galectin Therapeutics Revenue

Galectin Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Mar 31, 2026, Galectin Therapeutics had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
15
Market Cap
$149.43M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
Mar 31, 2025
Dec 31, 2023
Dec 31, 2022
Mar 31, 2022
Mar 31, 2021
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017